LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Gross Profit Growth (3y) (2017 - 2026)

Analysis

LivaNova (LIVN) Gross Profit Growth (3y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 9.77%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 18.71%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 7.71%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 12.24%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 14.82%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 9.36%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 7.11%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 14.95%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 8.95%
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 10.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.07%
Mar 31, 2026 11.87%
Dec 31, 2025 9.32%
Sep 30, 2025 12.73%
Jun 30, 2025 9.04%
Mar 31, 2025 8.69%
Dec 31, 2024 2.06%
Sep 30, 2024 9.43%
Jun 30, 2024 7.64%
Mar 31, 2024 7.54%
Dec 31, 2023 1.54%
Sep 30, 2023 10.99%
Jun 30, 2023 21.30%
Mar 31, 2023 1.74%
Dec 31, 2022 2.08%
Sep 30, 2022 -2.16%
Jun 30, 2022 -3.04%
Mar 31, 2022 0.38%
Dec 31, 2021 -0.80%
Sep 30, 2021 -1.10%